These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23220255)

  • 1. On the use of robust estimators for standard errors in the presence of clustering when clustering membership is misspecified.
    Desai M; Bryson SW; Robinson T
    Contemp Clin Trials; 2013 Mar; 34(2):248-56. PubMed ID: 23220255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
    Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
    Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias and inference from misspecified mixed-effect models in stepped wedge trial analysis.
    Thompson JA; Fielding KL; Davey C; Aiken AM; Hargreaves JR; Hayes RJ
    Stat Med; 2017 Oct; 36(23):3670-3682. PubMed ID: 28556355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculation in three-level cluster randomized trials using generalized estimating equation models.
    Liu J; Colditz GA
    Stat Med; 2020 Oct; 39(24):3347-3372. PubMed ID: 32720717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing appropriate methods for cost-effectiveness analysis of cluster randomized trials.
    Gomes M; Ng ES; Grieve R; Nixon R; Carpenter J; Thompson SG
    Med Decis Making; 2012; 32(2):350-61. PubMed ID: 22016450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study.
    Kahan BC; Forbes G; Ali Y; Jairath V; Bremner S; Harhay MO; Hooper R; Wright N; Eldridge SM; Leyrat C
    Trials; 2016 Sep; 17(1):438. PubMed ID: 27600609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling clustering and treatment effect heterogeneity in parallel and stepped-wedge cluster randomized trials.
    Hemming K; Taljaard M; Forbes A
    Stat Med; 2018 Mar; 37(6):883-898. PubMed ID: 29315688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a mixed effects logistic regression model for binary outcomes with unequal cluster size.
    Heo M; Leon AC
    J Biopharm Stat; 2005; 15(3):513-26. PubMed ID: 15920895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data.
    Bell ML; Rabe BA
    Trials; 2020 Feb; 21(1):148. PubMed ID: 32033617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choosing appropriate analysis methods for cluster randomised cross-over trials with a binary outcome.
    Morgan KE; Forbes AB; Keogh RH; Jairath V; Kahan BC
    Stat Med; 2017 Jan; 36(2):318-333. PubMed ID: 27680896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I error control for cluster randomized trials under varying small sample structures.
    Nugent JR; Kleinman KP
    BMC Med Res Methodol; 2021 Apr; 21(1):65. PubMed ID: 33812367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study.
    Huang S; Fiero MH; Bell ML
    Clin Trials; 2016 Aug; 13(4):445-9. PubMed ID: 27094487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal designs in three-level cluster randomized trials with a binary outcome.
    Liu J; Liu L; Colditz GA
    Stat Med; 2019 Sep; 38(20):3733-3746. PubMed ID: 31162709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reflection on modern methods: demystifying robust standard errors for epidemiologists.
    Mansournia MA; Nazemipour M; Naimi AI; Collins GS; Campbell MJ
    Int J Epidemiol; 2021 Mar; 50(1):346-351. PubMed ID: 33351919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling impure clusters in a cluster randomized controlled trial.
    Brown RL
    Res Nurs Health; 2013 Apr; 36(2):216-23. PubMed ID: 23322631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using cluster-robust standard errors when analyzing group-randomized trials with few clusters.
    Huang FL; Li X
    Behav Res Methods; 2022 Jun; 54(3):1181-1199. PubMed ID: 34505994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the bootstrap in analysing cost data from cluster randomised trials: some simulation results.
    Flynn TN; Peters TJ
    BMC Health Serv Res; 2004 Nov; 4(1):33. PubMed ID: 15550169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.